(Q83059944)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Matthew R Weir

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Shamkant Mulgaonkar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Laurence Chan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hamid Shidban

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Thomas H Waid

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Dennis Preston

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Roberto N Kalil

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Thomas C Pearson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

29 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

897-907

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21191361%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2010.492

19 January 2020

exact match

0 references

cites work

Improved graft survival after renal transplantation in the United States, 1988 to 1996

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

The natural history of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Mycophenolate mofetil and sirolimus combination in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Mycophenolate mofetil and its mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Long-term survival in renal transplant recipients with graft function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Rapamycin in transplantation: a review of the evidence

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Posttransplantation conversion to sirolimus-based immunosuppression: a single center experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Reduced exposure to calcineurin inhibitors in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

The stability of the glomerular filtration rate after renal transplantation is improving

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

GFR determined by nonradiolabeled iothalamate using capillary electrophoresis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021

The Banff 97 working classification of renal allograft pathology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.492

7 January 2021